The Chief Product Officer role in HealthTech has always been more complex than its equivalent in consumer software.
Clinical validation, regulatory pathway, patient safety obligations – these aren’t considerations that get layered on top of product strategy. In the best HealthTech companies, they are product strategy. And as the sector matures, the CPO role is being redefined around exactly that reality.
This piece is for HealthTech founders, CEOs, and People leaders thinking about their first Product Leadership Hire or the evolution of an existing one. It covers what the role looks like today, why it’s changing, and what good looks like when you’re hiring at this level.
Why the CPO Role Is Shifting
A few years ago, the HealthTech CPO looked a lot like a standard SaaS CPO. The primary accountability was product delivery: roadmap ownership, squad leadership, shipping features on time. Clinical and regulatory considerations were handled elsewhere, often by a separate Medical Affairs or Regulatory Affairs function, and the CPO’s job was to translate those requirements into product decisions.
That model is breaking down. Several forces are pushing the CPO role into new territory.
Regulatory frameworks have become product-defining. FDA’s evolving guidance on Software as a Medical Device (SaMD), the EU MDR transition, and the MHRA’s post-Brexit digital health framework have made regulatory pathway a core product design question, not a post-development compliance check. CPOs who don’t understand these frameworks are making product bets they can’t fully evaluate.
Payers and health systems are demanding clinical evidence. The era of selling digital health on UX and engagement metrics alone is effectively over for any company targeting health system or insurer contracts. Demonstrating clinical validity through real-world evidence, trial design, or outcomes data is now a commercial requirement. That puts the CPO at the intersection of product, clinical, and commercial in a way that didn’t exist five years ago.
AI is creating new accountability questions. As HealthTech companies embed AI into clinical workflows, diagnostic tools, and patient-facing applications, the CPO increasingly owns decisions with direct patient safety implications. That requires a different kind of seniority and a different risk mindset than managing a consumer product backlog.
What a Strong HealthTech CPO Profile Looks Like in 2026
The profiles that are succeeding at CPO level in HealthTech right now share a few consistent characteristics.
Clinical or Scientific Literacy
This doesn’t mean a clinical background is required. It means the CPO can hold a credible conversation with a Chief Medical Officer, understand what a clinical study design actually means for the product roadmap, and make sensible trade-offs when clinical evidence timelines conflict with commercial pressure. Candidates who have worked in companies with strong clinical or scientific cultures tend to develop this fluency even without a clinical background themselves.
Regulatory Pathway Experience
Direct experience navigating FDA, MHRA, or EMA regulatory processes as part of a product role is increasingly non-negotiable for CPOs at companies in the SaMD or medical device space. For digital health companies outside the device classification, the requirement is softer, but familiarity with the regulatory environment is still a meaningful differentiator.
Commercial Accountability
The best HealthTech CPOs understand the revenue model. Whether that’s a health system SaaS contract, a payer partnership, or a direct-to-consumer subscription, the CPO needs to connect product decisions to commercial outcomes. This is the area where many technically strong HealthTech product leaders fall short at CPO level.
Scaled Team Leadership
A CPO hire at Series B or beyond is an exec hire, not a senior individual contributor. The ability to build, structure, and lead a multi-disciplinary product function, including clinical product managers, regulatory-aware engineers, and UX specialists, is a core requirement.
When to Make the CPO Hire
The most common mistake HealthTech founders make with this hire is timing. Waiting until the product function is already struggling produces a CPO who spends their first 12 months fixing problems rather than building. Hiring too early, before the product direction is clear, can result in a CPO who shapes the product around their own instincts rather than market evidence.
The right moment is typically when the product-market fit hypothesis is validated, when regulatory pathway is becoming a defined programme rather than an open question, and when the team is large enough that a VP of Product or senior PM can no longer hold the full function together. At that point, the CPO hire becomes a commercial decision as much as an organisational one.
How Storm3 Supports HealthTech Executive Hiring
Storm3’s HealthTech Product Management recruitment team works with founders, boards, and People leaders across the HealthTech spectrum on senior product hiring.
Our network spans CPOs and VPs of Product at Digital Therapeutics and Telehealth companies through to early-stage founders making their first exec product hire.
As HealthTech executive search becomes an increasingly important part of how we work with clients, we’re building specific capability around CPO and VP Product mandates where clinical, regulatory, and commercial complexity requires a specialist search approach.
Hiring a CPO or senior product leader?
Submit your vacancy and our team will be in touch.
